feed,title,long_url,short_url
Investors,"Alnylam Jumps As A New Approval Sets Up Its Next Battle With Pfizer, BridgeBio",https://www.investors.com/news/technology/alnylam-stock-amvuttra-approval-cardiomyopathy-pfizer-bridgebio/,https://da.gd/JxR9
